David A. Scott

6.6k total citations · 2 hit papers
115 papers, 3.5k citations indexed

About

David A. Scott is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, David A. Scott has authored 115 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 17 papers in Surgery and 13 papers in General Health Professions. Recurrent topics in David A. Scott's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Meta-analysis and systematic reviews (11 papers) and Diabetes Treatment and Management (8 papers). David A. Scott is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Meta-analysis and systematic reviews (11 papers) and Diabetes Treatment and Management (8 papers). David A. Scott collaborates with scholars based in United Kingdom, United States and Switzerland. David A. Scott's co-authors include Neil Hawkins, Mandy Ryan, Beth Woods, Emma Loveman, C. Robb, Catherine Reeves, Elizabeth M. Russell, Angela Bate, Edwin van Teijlingen and Norman Waugh and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Diabetes Care.

In The Last Decade

David A. Scott

112 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

2011 604 citations David C. Hoaglin, Neil Hawkins et al. Value in Health profile →
Eliciting public preferences for healthcare: a systematic review of techniques

2001 510 citations David A. Scott et al. Health Technology Assessment profile →

Peers

Countries citing papers authored by David A. Scott

Since Specialization

Citations

This map shows the geographic impact of David A. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Scott more than expected).

Fields of papers citing papers by David A. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Scott. The network helps show where David A. Scott may publish in the future.

Co-authorship network of co-authors of David A. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Scott. A scholar is included among the top collaborators of David A. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Scott. David A. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aprocitentan for Blood Pressure Reduction in Black Patients 2025 ·Hypertension ·John M. Flack, Markus P. Schlaich, Michael A. Weber, (unknown), Krzysztof Narkiewicz, Martine Clozel, Roland F. Dreier, Nabil Andrawis, Parisa Danaietash, Nashwa Gabra, David A. Scott, Ji‐Guang Wang, Keith C. Ferdinand	2
2	Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trial 2024 ·BMJ Open ·(unknown), Ethaar El‐Emir, (unknown), Marko Topalovic, Rachael A Evans, Richard Russell, Karl Sylvester, (unknown), Anthony Paulo Sunjaya, David A. Scott, A Toby Prevost, Jennifer Harvey, Stephanie Taylor, Nicholas S Hopkinson, Samantha S.C. Kon, Ian Jarrold, (unknown), Winston Banya, William D‐C Man	2
3	Transperineal biopsy devices in people with suspected prostate cancer - a systematic review and economic evaluation 2024 ·Health Technology Assessment ·(unknown), (unknown), Emma Maund, David A. Scott, Joanne Lord, Joanna Picot, Jonathan Shepherd	1
4	P08 Long-term comparative efficacy and safety of risdiplam versus nusinersen in children with Type 1 spinal muscular atrophy (SMA) 2023 ·Neuromuscular Disorders ·Gautam Sajeev, Rachel Evans, Neil Hawkins, (unknown), David A. Scott, J. Nam, S.S. Sutherland, (unknown)	2
5	Spirometry services in England post-pandemic and the potential role of AI support software: a qualitative study of challenges and opportunities 2023 ·British Journal of General Practice ·(unknown), Stephanie Taylor, Marko Topalovic, Richard Russell, Rachael A Evans, (unknown), (unknown), Anthony Paulo Sunjaya, David A. Scott, A Toby Prevost, (unknown), Jennifer Harvey, Nicholas S Hopkinson, Samantha S.C. Kon, Suhani Patel, Ian Jarrold, (unknown), William D‐C Man, Anne Hutchinson	12
6	The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation 2015 ·Health Technology Assessment ·Emma Loveman, Vicky R Copley, Jill L Colquitt, David A. Scott, Andrew Clegg, Jeremy Jones, Katherine Ma O’Reilly, Sally Singh, Claudia Bausewein, Athol U. Wells	31
7	Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial 2015 ·Diabetes Care ·Melanie J. Davies, Stephen C. Bain, Stephen L. Atkin, Peter Rossing, David A. Scott, Минара Шамхаловна Шамхалова, Heidrun Bosch‐Traberg, (unknown), Guillermo E. Umpierrez	174
8	‘Arm‐based’ parameterization for network meta‐analysis 2015 ·Research Synthesis Methods ·Neil Hawkins, David A. Scott, Beth Woods	22
9	Time Ratios Or Hazard Ratios: Accelerating Toward A New Approach? 2015 ·Value in Health ·(unknown), (unknown), (unknown), Stuart Mealing, David A. Scott	1
10	A Conceptual Search Filter to Identify Real-World Evidence 2015 ·Value in Health ·(unknown), J.C. Thompson, (unknown), David A. Scott	3
11	Confronting Heterogeneity: Using Systematic Review Effectively for Meta-Analysis 2013 ·Value in Health ·Joan Quigley, Beth Woods, J.C. Thompson, Peter Bryden, David A. Scott	7
12	Social Camouflage: Interpreting Male Student Veterans' Behavior for Residence Life Professionals. 2012 ·The Journal of College and University Student Housing ·(unknown), David A. Scott, (unknown), Tony W. Cawthon	0
13	PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or Liraglutide 2011 ·Value in Health ·David A. Scott, Kristina S. Boye, (unknown), Jennie H. Best, (unknown)	2
14	Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2 breakdown → 2011 ·Value in Health ·David C. Hoaglin, Neil Hawkins, Jeroen P. Jansen, David A. Scott, Robbin Itzler, Joseph C. Cappelleri, Cornelis Boersma, David R. Thompson, Kay Larholt, Mireya Díaz, Annabel Barrett	604
15	No Study Left Behind: A Network Meta-Analysis in Non–Small-Cell Lung Cancer Demonstrating the Importance of Considering All Relevant Data 2009 ·Value in Health ·Neil Hawkins, David A. Scott, Beth Woods, Nicholas Thatcher	35
16	Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: A systematic review and economic evaluation 2007 ·International Journal of Technology Assessment in Health Care ·Andrew Clegg, David A. Scott, Emma Loveman, Jill L Colquitt, Pam Royle, Jackie Bryant	32
17	The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation 2005 ·Health Technology Assessment ·Andrew Clegg, David A. Scott, Emma Loveman, Jill L Colquitt, Jolie Hutchinson, Pamela Royle, J Bryant	45
18	Portability of licensure in Canada based on accreditation and certification. 2003 ·PubMed ·Jack D. Gerrow, Marcia A. Boyd, David A. Scott	2
19	Lessons from capital charging in the UK National Health Service 1996 ·ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) ·David A. Scott, David Heald	2
20	The vascular surgical society of Great Britain and Ireland 1996 ·British journal of surgery ·David A. Scott, Shandra L. Knight, David Berridge, J.I. Spark, Nigel Horlock, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact